Cargando…
Bortezomib/ciprofloxacin/tocilizumab: Various toxicities and lack of efficacy with an off label treatment: 2 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461394/ http://dx.doi.org/10.1007/s40278-021-02720-0 |
Ejemplares similares
-
Methylprednisolone/tocilizumab: Various toxicities, off label use and lack of efficacy: 2 case reports
Publicado: (2022) -
Tocilizumab: Off label use and lack of efficacy: case report
Publicado: (2021) -
Remdesivir/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2022) -
Tocilizumab: Lack of efficacy following off-label use: case report
Publicado: (2022) -
Dexamethasone/tocilizumab: Off-label-use and lack of efficacy: case report
Publicado: (2021)